Ophthotech Corporation to Present at 31st Annual J.P. Morgan Healthcare Conference
1/3/2013 6:21:31 AM
Ophthotech Corp. announced today that the company will participate in the 31st Annual J.P. Morgan Healthcare Conference to be held Jan. 7-10, 2013. Samir Patel, M.D., president and chief executive officer of Ophthotech, will deliver a presentation on Mon., Jan. 7 at 2:30 p.m. Pacific Standard Time (PST) in presentation room Elizabethan C/D at the Westin St. Francis Hotel, San Francisco. The presentation will focus on Ophthotech’s lead compound Fovista™ (anti-PDGF agent) for the treatment of neovascular age-related macular degeneration (wet AMD).